Global Medical Device Viral Inactivation Testing Supply, Demand and Key Producers, 2026-2032
The global Medical Device Viral Inactivation Testing market size is expected to reach $ 538 million by 2032, rising at a market growth of 14.6% CAGR during the forecast period (2026-2032).
Medical Device Viral Inactivation Testing is a service project specifically designed for medical devices that come into contact with biological fluids or tissues. This testing ensures that the device effectively eliminates or inactivates viruses, thereby preventing the transmission of infections during medical procedures. The test involves subjecting the device to a controlled environment with a known virus concentration and assessing its ability to reduce the viral load to an acceptable level. The significance of Medical Device Viral Inactivation Testing lies in its role in maintaining patient safety and preventing healthcare-associated infections. The functional benefits of this testing include the validation of the device's effectiveness in inactivating viruses, which is crucial for devices intended for reuse or those that come into direct contact with patients. By confirming the device's viral inactivation capabilities, this testing service contributes to the overall quality and reliability of medical devices.
In the future, the development trends of the Medical Device Viral Inactivation Testing industry will primarily manifest in the innovation of testing technologies and methods, updates to testing standards, the development of personalized testing solutions, the enhancement of automation and intelligence in testing processes, the advancement of internationalization and standardization, improvements in cost-effectiveness, changes in market demand, and shifts in the regulatory environment. With advancements in science and technology, new testing technologies and methods will be developed to enhance the accuracy and efficiency of viral inactivation testing, adapting to the characteristics of different medical devices and viruses. Automated and intelligent testing processes will utilize advanced automated equipment and analytical software to improve accuracy and efficiency while reducing human errors. The advancement of internationalization and standardization will ensure global recognition of testing results, while improvements in cost-effectiveness will make viral inactivation testing more economically viable. As medical technology progresses and new medical devices emerge, the demand for viral inactivation testing may change, requiring testing institutions to adapt to new market needs. Regulatory agencies may impose higher requirements for the viral inactivation performance of medical devices, necessitating testing institutions to adapt to these changes to ensure compliance of their services. These comprehensive trends will collectively drive the development of the Medical Device Viral Inactivation Testing industry, providing more accurate, efficient, and reliable services to the medical device industry.
This report studies the global Medical Device Viral Inactivation Testing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Medical Device Viral Inactivation Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Medical Device Viral Inactivation Testing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Medical Device Viral Inactivation Testing total market, 2021-2032, (USD Million)
Global Medical Device Viral Inactivation Testing total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Medical Device Viral Inactivation Testing total market, key domestic companies, and share, (USD Million)
Global Medical Device Viral Inactivation Testing revenue by player, revenue and market share 2021-2026, (USD Million)
Global Medical Device Viral Inactivation Testing total market by Type, CAGR, 2021-2032, (USD Million)
Global Medical Device Viral Inactivation Testing total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Medical Device Viral Inactivation Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Charles River, Perfectus Biomed (NAMSA), Eurofins Scientific, Nelson Labs, Texcell, Intertek Group, LabCorp, Syensqo, SGS, Pacific BioLabs, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Medical Device Viral Inactivation Testing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Medical Device Viral Inactivation Testing Market, By Region:
1. How big is the global Medical Device Viral Inactivation Testing market?
2. What is the demand of the global Medical Device Viral Inactivation Testing market?
3. What is the year over year growth of the global Medical Device Viral Inactivation Testing market?
4. What is the total value of the global Medical Device Viral Inactivation Testing market?
5. Who are the Major Players in the global Medical Device Viral Inactivation Testing market?
6. What are the growth factors driving the market demand?
Medical Device Viral Inactivation Testing is a service project specifically designed for medical devices that come into contact with biological fluids or tissues. This testing ensures that the device effectively eliminates or inactivates viruses, thereby preventing the transmission of infections during medical procedures. The test involves subjecting the device to a controlled environment with a known virus concentration and assessing its ability to reduce the viral load to an acceptable level. The significance of Medical Device Viral Inactivation Testing lies in its role in maintaining patient safety and preventing healthcare-associated infections. The functional benefits of this testing include the validation of the device's effectiveness in inactivating viruses, which is crucial for devices intended for reuse or those that come into direct contact with patients. By confirming the device's viral inactivation capabilities, this testing service contributes to the overall quality and reliability of medical devices.
In the future, the development trends of the Medical Device Viral Inactivation Testing industry will primarily manifest in the innovation of testing technologies and methods, updates to testing standards, the development of personalized testing solutions, the enhancement of automation and intelligence in testing processes, the advancement of internationalization and standardization, improvements in cost-effectiveness, changes in market demand, and shifts in the regulatory environment. With advancements in science and technology, new testing technologies and methods will be developed to enhance the accuracy and efficiency of viral inactivation testing, adapting to the characteristics of different medical devices and viruses. Automated and intelligent testing processes will utilize advanced automated equipment and analytical software to improve accuracy and efficiency while reducing human errors. The advancement of internationalization and standardization will ensure global recognition of testing results, while improvements in cost-effectiveness will make viral inactivation testing more economically viable. As medical technology progresses and new medical devices emerge, the demand for viral inactivation testing may change, requiring testing institutions to adapt to new market needs. Regulatory agencies may impose higher requirements for the viral inactivation performance of medical devices, necessitating testing institutions to adapt to these changes to ensure compliance of their services. These comprehensive trends will collectively drive the development of the Medical Device Viral Inactivation Testing industry, providing more accurate, efficient, and reliable services to the medical device industry.
This report studies the global Medical Device Viral Inactivation Testing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Medical Device Viral Inactivation Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Medical Device Viral Inactivation Testing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Medical Device Viral Inactivation Testing total market, 2021-2032, (USD Million)
Global Medical Device Viral Inactivation Testing total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Medical Device Viral Inactivation Testing total market, key domestic companies, and share, (USD Million)
Global Medical Device Viral Inactivation Testing revenue by player, revenue and market share 2021-2026, (USD Million)
Global Medical Device Viral Inactivation Testing total market by Type, CAGR, 2021-2032, (USD Million)
Global Medical Device Viral Inactivation Testing total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Medical Device Viral Inactivation Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Charles River, Perfectus Biomed (NAMSA), Eurofins Scientific, Nelson Labs, Texcell, Intertek Group, LabCorp, Syensqo, SGS, Pacific BioLabs, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Medical Device Viral Inactivation Testing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Medical Device Viral Inactivation Testing Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- DNA-based
- RNA-based
- Enveloped Viruses
- Non-enveloped Viruses
- Biocompatibility Testing
- Microbiological & Reusability Validation
- Chemical Composition Analysis
- Active Implant Medical Devices
- Active Medical Equipment
- In Vitro Diagnostic Equipment
- Ophthalmic Medical Equipment
- Vascular Medical Equipment
- Other
- Charles River
- Perfectus Biomed (NAMSA)
- Eurofins Scientific
- Nelson Labs
- Texcell
- Intertek Group
- LabCorp
- Syensqo
- SGS
- Pacific BioLabs
- Creative Biogene
- ProPharma Group
- Cormica Lab (Wickham Micro)
- CTI
- WuXi AppTec
1. How big is the global Medical Device Viral Inactivation Testing market?
2. What is the demand of the global Medical Device Viral Inactivation Testing market?
3. What is the year over year growth of the global Medical Device Viral Inactivation Testing market?
4. What is the total value of the global Medical Device Viral Inactivation Testing market?
5. Who are the Major Players in the global Medical Device Viral Inactivation Testing market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Medical Device Viral Inactivation Testing Introduction
1.2 World Medical Device Viral Inactivation Testing Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Medical Device Viral Inactivation Testing Total Market by Region (by Headquarter Location)
1.3.1 World Medical Device Viral Inactivation Testing Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Medical Device Viral Inactivation Testing Revenue (2021-2032)
1.3.3 China Based Company Medical Device Viral Inactivation Testing Revenue (2021-2032)
1.3.4 Europe Based Company Medical Device Viral Inactivation Testing Revenue (2021-2032)
1.3.5 Japan Based Company Medical Device Viral Inactivation Testing Revenue (2021-2032)
1.3.6 South Korea Based Company Medical Device Viral Inactivation Testing Revenue (2021-2032)
1.3.7 ASEAN Based Company Medical Device Viral Inactivation Testing Revenue (2021-2032)
1.3.8 India Based Company Medical Device Viral Inactivation Testing Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Medical Device Viral Inactivation Testing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Medical Device Viral Inactivation Testing Consumption Value (2021-2032)
2.2 World Medical Device Viral Inactivation Testing Consumption Value by Region
2.2.1 World Medical Device Viral Inactivation Testing Consumption Value by Region (2021-2026)
2.2.2 World Medical Device Viral Inactivation Testing Consumption Value Forecast by Region (2027-2032)
2.3 United States Medical Device Viral Inactivation Testing Consumption Value (2021-2032)
2.4 China Medical Device Viral Inactivation Testing Consumption Value (2021-2032)
2.5 Europe Medical Device Viral Inactivation Testing Consumption Value (2021-2032)
2.6 Japan Medical Device Viral Inactivation Testing Consumption Value (2021-2032)
2.7 South Korea Medical Device Viral Inactivation Testing Consumption Value (2021-2032)
2.8 ASEAN Medical Device Viral Inactivation Testing Consumption Value (2021-2032)
2.9 India Medical Device Viral Inactivation Testing Consumption Value (2021-2032)
3 WORLD MEDICAL DEVICE VIRAL INACTIVATION TESTING COMPANIES COMPETITIVE ANALYSIS
3.1 World Medical Device Viral Inactivation Testing Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Medical Device Viral Inactivation Testing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Medical Device Viral Inactivation Testing in 2025
3.2.3 Global Concentration Ratios (CR8) for Medical Device Viral Inactivation Testing in 2025
3.3 Medical Device Viral Inactivation Testing Company Evaluation Quadrant
3.4 Medical Device Viral Inactivation Testing Market: Overall Company Footprint Analysis
3.4.1 Medical Device Viral Inactivation Testing Market: Region Footprint
3.4.2 Medical Device Viral Inactivation Testing Market: Company Product Type Footprint
3.4.3 Medical Device Viral Inactivation Testing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Medical Device Viral Inactivation Testing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Medical Device Viral Inactivation Testing Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Medical Device Viral Inactivation Testing Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Medical Device Viral Inactivation Testing Consumption Value Comparison
4.2.1 United States VS China: Medical Device Viral Inactivation Testing Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Medical Device Viral Inactivation Testing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Medical Device Viral Inactivation Testing Companies and Market Share, 2021-2026
4.3.1 United States Based Medical Device Viral Inactivation Testing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Medical Device Viral Inactivation Testing Revenue, (2021-2026)
4.4 China Based Companies Medical Device Viral Inactivation Testing Revenue and Market Share, 2021-2026
4.4.1 China Based Medical Device Viral Inactivation Testing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Medical Device Viral Inactivation Testing Revenue, (2021-2026)
4.5 Rest of World Based Medical Device Viral Inactivation Testing Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Medical Device Viral Inactivation Testing Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Medical Device Viral Inactivation Testing Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Medical Device Viral Inactivation Testing Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 DNA-based
5.2.2 RNA-based
5.3 Market Segment by Type
5.3.1 World Medical Device Viral Inactivation Testing Market Size by Type (2021-2026)
5.3.2 World Medical Device Viral Inactivation Testing Market Size by Type (2027-2032)
5.3.3 World Medical Device Viral Inactivation Testing Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY BIOLOGICAL CHARACTERISTICS & STRUCTURE OF VIRUSE
6.1 World Medical Device Viral Inactivation Testing Market Size Overview by Biological Characteristics & Structure of Viruse: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Biological Characteristics & Structure of Viruse
6.2.1 Enveloped Viruses
6.2.2 Non-enveloped Viruses
6.3 Market Segment by Biological Characteristics & Structure of Viruse
6.3.1 World Medical Device Viral Inactivation Testing Market Size by Biological Characteristics & Structure of Viruse (2021-2026)
6.3.2 World Medical Device Viral Inactivation Testing Market Size by Biological Characteristics & Structure of Viruse (2027-2032)
6.3.3 World Medical Device Viral Inactivation Testing Market Size Market Share by Biological Characteristics & Structure of Viruse (2027-2032)
7 MARKET ANALYSIS BY TESTING METHOD
7.1 World Medical Device Viral Inactivation Testing Market Size Overview by Testing Method: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Testing Method
7.2.1 Biocompatibility Testing
7.2.2 Microbiological & Reusability Validation
7.2.3 Chemical Composition Analysis
7.3 Market Segment by Testing Method
7.3.1 World Medical Device Viral Inactivation Testing Market Size by Testing Method (2021-2026)
7.3.2 World Medical Device Viral Inactivation Testing Market Size by Testing Method (2027-2032)
7.3.3 World Medical Device Viral Inactivation Testing Market Size Market Share by Testing Method (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Medical Device Viral Inactivation Testing Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Active Implant Medical Devices
8.2.2 Active Medical Equipment
8.2.3 In Vitro Diagnostic Equipment
8.2.4 Ophthalmic Medical Equipment
8.2.5 Vascular Medical Equipment
8.2.6 Other
8.3 Market Segment by Application
8.3.1 World Medical Device Viral Inactivation Testing Market Size by Application (2021-2026)
8.3.2 World Medical Device Viral Inactivation Testing Market Size by Application (2027-2032)
8.3.3 World Medical Device Viral Inactivation Testing Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Charles River
9.1.1 Charles River Details
9.1.2 Charles River Major Business
9.1.3 Charles River Medical Device Viral Inactivation Testing Product and Services
9.1.4 Charles River Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Charles River Recent Developments/Updates
9.1.6 Charles River Competitive Strengths & Weaknesses
9.2 Perfectus Biomed (NAMSA)
9.2.1 Perfectus Biomed (NAMSA) Details
9.2.2 Perfectus Biomed (NAMSA) Major Business
9.2.3 Perfectus Biomed (NAMSA) Medical Device Viral Inactivation Testing Product and Services
9.2.4 Perfectus Biomed (NAMSA) Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Perfectus Biomed (NAMSA) Recent Developments/Updates
9.2.6 Perfectus Biomed (NAMSA) Competitive Strengths & Weaknesses
9.3 Eurofins Scientific
9.3.1 Eurofins Scientific Details
9.3.2 Eurofins Scientific Major Business
9.3.3 Eurofins Scientific Medical Device Viral Inactivation Testing Product and Services
9.3.4 Eurofins Scientific Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Eurofins Scientific Recent Developments/Updates
9.3.6 Eurofins Scientific Competitive Strengths & Weaknesses
9.4 Nelson Labs
9.4.1 Nelson Labs Details
9.4.2 Nelson Labs Major Business
9.4.3 Nelson Labs Medical Device Viral Inactivation Testing Product and Services
9.4.4 Nelson Labs Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Nelson Labs Recent Developments/Updates
9.4.6 Nelson Labs Competitive Strengths & Weaknesses
9.5 Texcell
9.5.1 Texcell Details
9.5.2 Texcell Major Business
9.5.3 Texcell Medical Device Viral Inactivation Testing Product and Services
9.5.4 Texcell Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Texcell Recent Developments/Updates
9.5.6 Texcell Competitive Strengths & Weaknesses
9.6 Intertek Group
9.6.1 Intertek Group Details
9.6.2 Intertek Group Major Business
9.6.3 Intertek Group Medical Device Viral Inactivation Testing Product and Services
9.6.4 Intertek Group Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Intertek Group Recent Developments/Updates
9.6.6 Intertek Group Competitive Strengths & Weaknesses
9.7 LabCorp
9.7.1 LabCorp Details
9.7.2 LabCorp Major Business
9.7.3 LabCorp Medical Device Viral Inactivation Testing Product and Services
9.7.4 LabCorp Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 LabCorp Recent Developments/Updates
9.7.6 LabCorp Competitive Strengths & Weaknesses
9.8 Syensqo
9.8.1 Syensqo Details
9.8.2 Syensqo Major Business
9.8.3 Syensqo Medical Device Viral Inactivation Testing Product and Services
9.8.4 Syensqo Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Syensqo Recent Developments/Updates
9.8.6 Syensqo Competitive Strengths & Weaknesses
9.9 SGS
9.9.1 SGS Details
9.9.2 SGS Major Business
9.9.3 SGS Medical Device Viral Inactivation Testing Product and Services
9.9.4 SGS Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 SGS Recent Developments/Updates
9.9.6 SGS Competitive Strengths & Weaknesses
9.10 Pacific BioLabs
9.10.1 Pacific BioLabs Details
9.10.2 Pacific BioLabs Major Business
9.10.3 Pacific BioLabs Medical Device Viral Inactivation Testing Product and Services
9.10.4 Pacific BioLabs Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Pacific BioLabs Recent Developments/Updates
9.10.6 Pacific BioLabs Competitive Strengths & Weaknesses
9.11 Creative Biogene
9.11.1 Creative Biogene Details
9.11.2 Creative Biogene Major Business
9.11.3 Creative Biogene Medical Device Viral Inactivation Testing Product and Services
9.11.4 Creative Biogene Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Creative Biogene Recent Developments/Updates
9.11.6 Creative Biogene Competitive Strengths & Weaknesses
9.12 ProPharma Group
9.12.1 ProPharma Group Details
9.12.2 ProPharma Group Major Business
9.12.3 ProPharma Group Medical Device Viral Inactivation Testing Product and Services
9.12.4 ProPharma Group Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 ProPharma Group Recent Developments/Updates
9.12.6 ProPharma Group Competitive Strengths & Weaknesses
9.13 Cormica Lab (Wickham Micro)
9.13.1 Cormica Lab (Wickham Micro) Details
9.13.2 Cormica Lab (Wickham Micro) Major Business
9.13.3 Cormica Lab (Wickham Micro) Medical Device Viral Inactivation Testing Product and Services
9.13.4 Cormica Lab (Wickham Micro) Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Cormica Lab (Wickham Micro) Recent Developments/Updates
9.13.6 Cormica Lab (Wickham Micro) Competitive Strengths & Weaknesses
9.14 CTI
9.14.1 CTI Details
9.14.2 CTI Major Business
9.14.3 CTI Medical Device Viral Inactivation Testing Product and Services
9.14.4 CTI Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 CTI Recent Developments/Updates
9.14.6 CTI Competitive Strengths & Weaknesses
9.15 WuXi AppTec
9.15.1 WuXi AppTec Details
9.15.2 WuXi AppTec Major Business
9.15.3 WuXi AppTec Medical Device Viral Inactivation Testing Product and Services
9.15.4 WuXi AppTec Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 WuXi AppTec Recent Developments/Updates
9.15.6 WuXi AppTec Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Medical Device Viral Inactivation Testing Industry Chain
10.2 Medical Device Viral Inactivation Testing Upstream Analysis
10.3 Medical Device Viral Inactivation Testing Midstream Analysis
10.4 Medical Device Viral Inactivation Testing Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Medical Device Viral Inactivation Testing Introduction
1.2 World Medical Device Viral Inactivation Testing Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Medical Device Viral Inactivation Testing Total Market by Region (by Headquarter Location)
1.3.1 World Medical Device Viral Inactivation Testing Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Medical Device Viral Inactivation Testing Revenue (2021-2032)
1.3.3 China Based Company Medical Device Viral Inactivation Testing Revenue (2021-2032)
1.3.4 Europe Based Company Medical Device Viral Inactivation Testing Revenue (2021-2032)
1.3.5 Japan Based Company Medical Device Viral Inactivation Testing Revenue (2021-2032)
1.3.6 South Korea Based Company Medical Device Viral Inactivation Testing Revenue (2021-2032)
1.3.7 ASEAN Based Company Medical Device Viral Inactivation Testing Revenue (2021-2032)
1.3.8 India Based Company Medical Device Viral Inactivation Testing Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Medical Device Viral Inactivation Testing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Medical Device Viral Inactivation Testing Consumption Value (2021-2032)
2.2 World Medical Device Viral Inactivation Testing Consumption Value by Region
2.2.1 World Medical Device Viral Inactivation Testing Consumption Value by Region (2021-2026)
2.2.2 World Medical Device Viral Inactivation Testing Consumption Value Forecast by Region (2027-2032)
2.3 United States Medical Device Viral Inactivation Testing Consumption Value (2021-2032)
2.4 China Medical Device Viral Inactivation Testing Consumption Value (2021-2032)
2.5 Europe Medical Device Viral Inactivation Testing Consumption Value (2021-2032)
2.6 Japan Medical Device Viral Inactivation Testing Consumption Value (2021-2032)
2.7 South Korea Medical Device Viral Inactivation Testing Consumption Value (2021-2032)
2.8 ASEAN Medical Device Viral Inactivation Testing Consumption Value (2021-2032)
2.9 India Medical Device Viral Inactivation Testing Consumption Value (2021-2032)
3 WORLD MEDICAL DEVICE VIRAL INACTIVATION TESTING COMPANIES COMPETITIVE ANALYSIS
3.1 World Medical Device Viral Inactivation Testing Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Medical Device Viral Inactivation Testing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Medical Device Viral Inactivation Testing in 2025
3.2.3 Global Concentration Ratios (CR8) for Medical Device Viral Inactivation Testing in 2025
3.3 Medical Device Viral Inactivation Testing Company Evaluation Quadrant
3.4 Medical Device Viral Inactivation Testing Market: Overall Company Footprint Analysis
3.4.1 Medical Device Viral Inactivation Testing Market: Region Footprint
3.4.2 Medical Device Viral Inactivation Testing Market: Company Product Type Footprint
3.4.3 Medical Device Viral Inactivation Testing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Medical Device Viral Inactivation Testing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Medical Device Viral Inactivation Testing Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Medical Device Viral Inactivation Testing Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Medical Device Viral Inactivation Testing Consumption Value Comparison
4.2.1 United States VS China: Medical Device Viral Inactivation Testing Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Medical Device Viral Inactivation Testing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Medical Device Viral Inactivation Testing Companies and Market Share, 2021-2026
4.3.1 United States Based Medical Device Viral Inactivation Testing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Medical Device Viral Inactivation Testing Revenue, (2021-2026)
4.4 China Based Companies Medical Device Viral Inactivation Testing Revenue and Market Share, 2021-2026
4.4.1 China Based Medical Device Viral Inactivation Testing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Medical Device Viral Inactivation Testing Revenue, (2021-2026)
4.5 Rest of World Based Medical Device Viral Inactivation Testing Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Medical Device Viral Inactivation Testing Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Medical Device Viral Inactivation Testing Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Medical Device Viral Inactivation Testing Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 DNA-based
5.2.2 RNA-based
5.3 Market Segment by Type
5.3.1 World Medical Device Viral Inactivation Testing Market Size by Type (2021-2026)
5.3.2 World Medical Device Viral Inactivation Testing Market Size by Type (2027-2032)
5.3.3 World Medical Device Viral Inactivation Testing Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY BIOLOGICAL CHARACTERISTICS & STRUCTURE OF VIRUSE
6.1 World Medical Device Viral Inactivation Testing Market Size Overview by Biological Characteristics & Structure of Viruse: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Biological Characteristics & Structure of Viruse
6.2.1 Enveloped Viruses
6.2.2 Non-enveloped Viruses
6.3 Market Segment by Biological Characteristics & Structure of Viruse
6.3.1 World Medical Device Viral Inactivation Testing Market Size by Biological Characteristics & Structure of Viruse (2021-2026)
6.3.2 World Medical Device Viral Inactivation Testing Market Size by Biological Characteristics & Structure of Viruse (2027-2032)
6.3.3 World Medical Device Viral Inactivation Testing Market Size Market Share by Biological Characteristics & Structure of Viruse (2027-2032)
7 MARKET ANALYSIS BY TESTING METHOD
7.1 World Medical Device Viral Inactivation Testing Market Size Overview by Testing Method: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Testing Method
7.2.1 Biocompatibility Testing
7.2.2 Microbiological & Reusability Validation
7.2.3 Chemical Composition Analysis
7.3 Market Segment by Testing Method
7.3.1 World Medical Device Viral Inactivation Testing Market Size by Testing Method (2021-2026)
7.3.2 World Medical Device Viral Inactivation Testing Market Size by Testing Method (2027-2032)
7.3.3 World Medical Device Viral Inactivation Testing Market Size Market Share by Testing Method (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Medical Device Viral Inactivation Testing Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Active Implant Medical Devices
8.2.2 Active Medical Equipment
8.2.3 In Vitro Diagnostic Equipment
8.2.4 Ophthalmic Medical Equipment
8.2.5 Vascular Medical Equipment
8.2.6 Other
8.3 Market Segment by Application
8.3.1 World Medical Device Viral Inactivation Testing Market Size by Application (2021-2026)
8.3.2 World Medical Device Viral Inactivation Testing Market Size by Application (2027-2032)
8.3.3 World Medical Device Viral Inactivation Testing Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Charles River
9.1.1 Charles River Details
9.1.2 Charles River Major Business
9.1.3 Charles River Medical Device Viral Inactivation Testing Product and Services
9.1.4 Charles River Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Charles River Recent Developments/Updates
9.1.6 Charles River Competitive Strengths & Weaknesses
9.2 Perfectus Biomed (NAMSA)
9.2.1 Perfectus Biomed (NAMSA) Details
9.2.2 Perfectus Biomed (NAMSA) Major Business
9.2.3 Perfectus Biomed (NAMSA) Medical Device Viral Inactivation Testing Product and Services
9.2.4 Perfectus Biomed (NAMSA) Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Perfectus Biomed (NAMSA) Recent Developments/Updates
9.2.6 Perfectus Biomed (NAMSA) Competitive Strengths & Weaknesses
9.3 Eurofins Scientific
9.3.1 Eurofins Scientific Details
9.3.2 Eurofins Scientific Major Business
9.3.3 Eurofins Scientific Medical Device Viral Inactivation Testing Product and Services
9.3.4 Eurofins Scientific Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Eurofins Scientific Recent Developments/Updates
9.3.6 Eurofins Scientific Competitive Strengths & Weaknesses
9.4 Nelson Labs
9.4.1 Nelson Labs Details
9.4.2 Nelson Labs Major Business
9.4.3 Nelson Labs Medical Device Viral Inactivation Testing Product and Services
9.4.4 Nelson Labs Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Nelson Labs Recent Developments/Updates
9.4.6 Nelson Labs Competitive Strengths & Weaknesses
9.5 Texcell
9.5.1 Texcell Details
9.5.2 Texcell Major Business
9.5.3 Texcell Medical Device Viral Inactivation Testing Product and Services
9.5.4 Texcell Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Texcell Recent Developments/Updates
9.5.6 Texcell Competitive Strengths & Weaknesses
9.6 Intertek Group
9.6.1 Intertek Group Details
9.6.2 Intertek Group Major Business
9.6.3 Intertek Group Medical Device Viral Inactivation Testing Product and Services
9.6.4 Intertek Group Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Intertek Group Recent Developments/Updates
9.6.6 Intertek Group Competitive Strengths & Weaknesses
9.7 LabCorp
9.7.1 LabCorp Details
9.7.2 LabCorp Major Business
9.7.3 LabCorp Medical Device Viral Inactivation Testing Product and Services
9.7.4 LabCorp Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 LabCorp Recent Developments/Updates
9.7.6 LabCorp Competitive Strengths & Weaknesses
9.8 Syensqo
9.8.1 Syensqo Details
9.8.2 Syensqo Major Business
9.8.3 Syensqo Medical Device Viral Inactivation Testing Product and Services
9.8.4 Syensqo Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Syensqo Recent Developments/Updates
9.8.6 Syensqo Competitive Strengths & Weaknesses
9.9 SGS
9.9.1 SGS Details
9.9.2 SGS Major Business
9.9.3 SGS Medical Device Viral Inactivation Testing Product and Services
9.9.4 SGS Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 SGS Recent Developments/Updates
9.9.6 SGS Competitive Strengths & Weaknesses
9.10 Pacific BioLabs
9.10.1 Pacific BioLabs Details
9.10.2 Pacific BioLabs Major Business
9.10.3 Pacific BioLabs Medical Device Viral Inactivation Testing Product and Services
9.10.4 Pacific BioLabs Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Pacific BioLabs Recent Developments/Updates
9.10.6 Pacific BioLabs Competitive Strengths & Weaknesses
9.11 Creative Biogene
9.11.1 Creative Biogene Details
9.11.2 Creative Biogene Major Business
9.11.3 Creative Biogene Medical Device Viral Inactivation Testing Product and Services
9.11.4 Creative Biogene Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Creative Biogene Recent Developments/Updates
9.11.6 Creative Biogene Competitive Strengths & Weaknesses
9.12 ProPharma Group
9.12.1 ProPharma Group Details
9.12.2 ProPharma Group Major Business
9.12.3 ProPharma Group Medical Device Viral Inactivation Testing Product and Services
9.12.4 ProPharma Group Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 ProPharma Group Recent Developments/Updates
9.12.6 ProPharma Group Competitive Strengths & Weaknesses
9.13 Cormica Lab (Wickham Micro)
9.13.1 Cormica Lab (Wickham Micro) Details
9.13.2 Cormica Lab (Wickham Micro) Major Business
9.13.3 Cormica Lab (Wickham Micro) Medical Device Viral Inactivation Testing Product and Services
9.13.4 Cormica Lab (Wickham Micro) Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Cormica Lab (Wickham Micro) Recent Developments/Updates
9.13.6 Cormica Lab (Wickham Micro) Competitive Strengths & Weaknesses
9.14 CTI
9.14.1 CTI Details
9.14.2 CTI Major Business
9.14.3 CTI Medical Device Viral Inactivation Testing Product and Services
9.14.4 CTI Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 CTI Recent Developments/Updates
9.14.6 CTI Competitive Strengths & Weaknesses
9.15 WuXi AppTec
9.15.1 WuXi AppTec Details
9.15.2 WuXi AppTec Major Business
9.15.3 WuXi AppTec Medical Device Viral Inactivation Testing Product and Services
9.15.4 WuXi AppTec Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 WuXi AppTec Recent Developments/Updates
9.15.6 WuXi AppTec Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Medical Device Viral Inactivation Testing Industry Chain
10.2 Medical Device Viral Inactivation Testing Upstream Analysis
10.3 Medical Device Viral Inactivation Testing Midstream Analysis
10.4 Medical Device Viral Inactivation Testing Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Medical Device Viral Inactivation Testing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Medical Device Viral Inactivation Testing Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Medical Device Viral Inactivation Testing Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Medical Device Viral Inactivation Testing Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Medical Device Viral Inactivation Testing Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Medical Device Viral Inactivation Testing Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Medical Device Viral Inactivation Testing Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Medical Device Viral Inactivation Testing Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Medical Device Viral Inactivation Testing Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Medical Device Viral Inactivation Testing Players in 2025
Table 12. World Medical Device Viral Inactivation Testing Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Medical Device Viral Inactivation Testing Company Evaluation Quadrant
Table 14. Head Office of Key Medical Device Viral Inactivation Testing Players
Table 15. Medical Device Viral Inactivation Testing Market: Company Product Type Footprint
Table 16. Medical Device Viral Inactivation Testing Market: Company Product Application Footprint
Table 17. Medical Device Viral Inactivation Testing Mergers & Acquisitions Activity
Table 18. United States VS China Medical Device Viral Inactivation Testing Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Medical Device Viral Inactivation Testing Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Medical Device Viral Inactivation Testing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Medical Device Viral Inactivation Testing Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Medical Device Viral Inactivation Testing Revenue Market Share (2021-2026)
Table 23. China Based Medical Device Viral Inactivation Testing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Medical Device Viral Inactivation Testing Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Medical Device Viral Inactivation Testing Revenue Market Share (2021-2026)
Table 26. Rest of World Based Medical Device Viral Inactivation Testing Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Medical Device Viral Inactivation Testing Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Medical Device Viral Inactivation Testing Revenue Market Share (2021-2026)
Table 29. World Medical Device Viral Inactivation Testing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Medical Device Viral Inactivation Testing Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Medical Device Viral Inactivation Testing Market Size by Type (2027-2032) & (USD Million)
Table 32. World Medical Device Viral Inactivation Testing Market Size by Biological Characteristics & Structure of Viruse, (USD Million), 2021 & 2025 & 2032
Table 33. World Medical Device Viral Inactivation Testing Market Size Value by Biological Characteristics & Structure of Viruse (2021-2026) & (USD Million)
Table 34. World Medical Device Viral Inactivation Testing Market Size by Biological Characteristics & Structure of Viruse (2027-2032) & (USD Million)
Table 35. World Medical Device Viral Inactivation Testing Market Size by Testing Method, (USD Million), 2021 & 2025 & 2032
Table 36. World Medical Device Viral Inactivation Testing Market Size Value by Testing Method (2021-2026) & (USD Million)
Table 37. World Medical Device Viral Inactivation Testing Market Size by Testing Method (2027-2032) & (USD Million)
Table 38. World Medical Device Viral Inactivation Testing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Medical Device Viral Inactivation Testing Market Size by Application (2021-2026) & (USD Million)
Table 40. World Medical Device Viral Inactivation Testing Market Size by Application (2027-2032) & (USD Million)
Table 41. Charles River Basic Information, Manufacturing Base and Competitors
Table 42. Charles River Major Business
Table 43. Charles River Medical Device Viral Inactivation Testing Product and Services
Table 44. Charles River Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Charles River Recent Developments/Updates
Table 46. Charles River Competitive Strengths & Weaknesses
Table 47. Perfectus Biomed (NAMSA) Basic Information, Manufacturing Base and Competitors
Table 48. Perfectus Biomed (NAMSA) Major Business
Table 49. Perfectus Biomed (NAMSA) Medical Device Viral Inactivation Testing Product and Services
Table 50. Perfectus Biomed (NAMSA) Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Perfectus Biomed (NAMSA) Recent Developments/Updates
Table 52. Perfectus Biomed (NAMSA) Competitive Strengths & Weaknesses
Table 53. Eurofins Scientific Basic Information, Manufacturing Base and Competitors
Table 54. Eurofins Scientific Major Business
Table 55. Eurofins Scientific Medical Device Viral Inactivation Testing Product and Services
Table 56. Eurofins Scientific Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Eurofins Scientific Recent Developments/Updates
Table 58. Eurofins Scientific Competitive Strengths & Weaknesses
Table 59. Nelson Labs Basic Information, Manufacturing Base and Competitors
Table 60. Nelson Labs Major Business
Table 61. Nelson Labs Medical Device Viral Inactivation Testing Product and Services
Table 62. Nelson Labs Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Nelson Labs Recent Developments/Updates
Table 64. Nelson Labs Competitive Strengths & Weaknesses
Table 65. Texcell Basic Information, Manufacturing Base and Competitors
Table 66. Texcell Major Business
Table 67. Texcell Medical Device Viral Inactivation Testing Product and Services
Table 68. Texcell Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Texcell Recent Developments/Updates
Table 70. Texcell Competitive Strengths & Weaknesses
Table 71. Intertek Group Basic Information, Manufacturing Base and Competitors
Table 72. Intertek Group Major Business
Table 73. Intertek Group Medical Device Viral Inactivation Testing Product and Services
Table 74. Intertek Group Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Intertek Group Recent Developments/Updates
Table 76. Intertek Group Competitive Strengths & Weaknesses
Table 77. LabCorp Basic Information, Manufacturing Base and Competitors
Table 78. LabCorp Major Business
Table 79. LabCorp Medical Device Viral Inactivation Testing Product and Services
Table 80. LabCorp Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. LabCorp Recent Developments/Updates
Table 82. LabCorp Competitive Strengths & Weaknesses
Table 83. Syensqo Basic Information, Manufacturing Base and Competitors
Table 84. Syensqo Major Business
Table 85. Syensqo Medical Device Viral Inactivation Testing Product and Services
Table 86. Syensqo Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Syensqo Recent Developments/Updates
Table 88. Syensqo Competitive Strengths & Weaknesses
Table 89. SGS Basic Information, Manufacturing Base and Competitors
Table 90. SGS Major Business
Table 91. SGS Medical Device Viral Inactivation Testing Product and Services
Table 92. SGS Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. SGS Recent Developments/Updates
Table 94. SGS Competitive Strengths & Weaknesses
Table 95. Pacific BioLabs Basic Information, Manufacturing Base and Competitors
Table 96. Pacific BioLabs Major Business
Table 97. Pacific BioLabs Medical Device Viral Inactivation Testing Product and Services
Table 98. Pacific BioLabs Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Pacific BioLabs Recent Developments/Updates
Table 100. Pacific BioLabs Competitive Strengths & Weaknesses
Table 101. Creative Biogene Basic Information, Manufacturing Base and Competitors
Table 102. Creative Biogene Major Business
Table 103. Creative Biogene Medical Device Viral Inactivation Testing Product and Services
Table 104. Creative Biogene Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Creative Biogene Recent Developments/Updates
Table 106. Creative Biogene Competitive Strengths & Weaknesses
Table 107. ProPharma Group Basic Information, Manufacturing Base and Competitors
Table 108. ProPharma Group Major Business
Table 109. ProPharma Group Medical Device Viral Inactivation Testing Product and Services
Table 110. ProPharma Group Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. ProPharma Group Recent Developments/Updates
Table 112. ProPharma Group Competitive Strengths & Weaknesses
Table 113. Cormica Lab (Wickham Micro) Basic Information, Manufacturing Base and Competitors
Table 114. Cormica Lab (Wickham Micro) Major Business
Table 115. Cormica Lab (Wickham Micro) Medical Device Viral Inactivation Testing Product and Services
Table 116. Cormica Lab (Wickham Micro) Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Cormica Lab (Wickham Micro) Recent Developments/Updates
Table 118. Cormica Lab (Wickham Micro) Competitive Strengths & Weaknesses
Table 119. CTI Basic Information, Manufacturing Base and Competitors
Table 120. CTI Major Business
Table 121. CTI Medical Device Viral Inactivation Testing Product and Services
Table 122. CTI Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. CTI Recent Developments/Updates
Table 124. CTI Competitive Strengths & Weaknesses
Table 125. WuXi AppTec Basic Information, Manufacturing Base and Competitors
Table 126. WuXi AppTec Major Business
Table 127. WuXi AppTec Medical Device Viral Inactivation Testing Product and Services
Table 128. WuXi AppTec Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. WuXi AppTec Recent Developments/Updates
Table 130. WuXi AppTec Competitive Strengths & Weaknesses
Table 131. Global Key Players of Medical Device Viral Inactivation Testing Upstream (Raw Materials)
Table 132. Global Medical Device Viral Inactivation Testing Typical Customers
Table 1. World Medical Device Viral Inactivation Testing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Medical Device Viral Inactivation Testing Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Medical Device Viral Inactivation Testing Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Medical Device Viral Inactivation Testing Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Medical Device Viral Inactivation Testing Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Medical Device Viral Inactivation Testing Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Medical Device Viral Inactivation Testing Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Medical Device Viral Inactivation Testing Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Medical Device Viral Inactivation Testing Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Medical Device Viral Inactivation Testing Players in 2025
Table 12. World Medical Device Viral Inactivation Testing Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Medical Device Viral Inactivation Testing Company Evaluation Quadrant
Table 14. Head Office of Key Medical Device Viral Inactivation Testing Players
Table 15. Medical Device Viral Inactivation Testing Market: Company Product Type Footprint
Table 16. Medical Device Viral Inactivation Testing Market: Company Product Application Footprint
Table 17. Medical Device Viral Inactivation Testing Mergers & Acquisitions Activity
Table 18. United States VS China Medical Device Viral Inactivation Testing Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Medical Device Viral Inactivation Testing Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Medical Device Viral Inactivation Testing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Medical Device Viral Inactivation Testing Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Medical Device Viral Inactivation Testing Revenue Market Share (2021-2026)
Table 23. China Based Medical Device Viral Inactivation Testing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Medical Device Viral Inactivation Testing Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Medical Device Viral Inactivation Testing Revenue Market Share (2021-2026)
Table 26. Rest of World Based Medical Device Viral Inactivation Testing Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Medical Device Viral Inactivation Testing Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Medical Device Viral Inactivation Testing Revenue Market Share (2021-2026)
Table 29. World Medical Device Viral Inactivation Testing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Medical Device Viral Inactivation Testing Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Medical Device Viral Inactivation Testing Market Size by Type (2027-2032) & (USD Million)
Table 32. World Medical Device Viral Inactivation Testing Market Size by Biological Characteristics & Structure of Viruse, (USD Million), 2021 & 2025 & 2032
Table 33. World Medical Device Viral Inactivation Testing Market Size Value by Biological Characteristics & Structure of Viruse (2021-2026) & (USD Million)
Table 34. World Medical Device Viral Inactivation Testing Market Size by Biological Characteristics & Structure of Viruse (2027-2032) & (USD Million)
Table 35. World Medical Device Viral Inactivation Testing Market Size by Testing Method, (USD Million), 2021 & 2025 & 2032
Table 36. World Medical Device Viral Inactivation Testing Market Size Value by Testing Method (2021-2026) & (USD Million)
Table 37. World Medical Device Viral Inactivation Testing Market Size by Testing Method (2027-2032) & (USD Million)
Table 38. World Medical Device Viral Inactivation Testing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Medical Device Viral Inactivation Testing Market Size by Application (2021-2026) & (USD Million)
Table 40. World Medical Device Viral Inactivation Testing Market Size by Application (2027-2032) & (USD Million)
Table 41. Charles River Basic Information, Manufacturing Base and Competitors
Table 42. Charles River Major Business
Table 43. Charles River Medical Device Viral Inactivation Testing Product and Services
Table 44. Charles River Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Charles River Recent Developments/Updates
Table 46. Charles River Competitive Strengths & Weaknesses
Table 47. Perfectus Biomed (NAMSA) Basic Information, Manufacturing Base and Competitors
Table 48. Perfectus Biomed (NAMSA) Major Business
Table 49. Perfectus Biomed (NAMSA) Medical Device Viral Inactivation Testing Product and Services
Table 50. Perfectus Biomed (NAMSA) Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Perfectus Biomed (NAMSA) Recent Developments/Updates
Table 52. Perfectus Biomed (NAMSA) Competitive Strengths & Weaknesses
Table 53. Eurofins Scientific Basic Information, Manufacturing Base and Competitors
Table 54. Eurofins Scientific Major Business
Table 55. Eurofins Scientific Medical Device Viral Inactivation Testing Product and Services
Table 56. Eurofins Scientific Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Eurofins Scientific Recent Developments/Updates
Table 58. Eurofins Scientific Competitive Strengths & Weaknesses
Table 59. Nelson Labs Basic Information, Manufacturing Base and Competitors
Table 60. Nelson Labs Major Business
Table 61. Nelson Labs Medical Device Viral Inactivation Testing Product and Services
Table 62. Nelson Labs Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Nelson Labs Recent Developments/Updates
Table 64. Nelson Labs Competitive Strengths & Weaknesses
Table 65. Texcell Basic Information, Manufacturing Base and Competitors
Table 66. Texcell Major Business
Table 67. Texcell Medical Device Viral Inactivation Testing Product and Services
Table 68. Texcell Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Texcell Recent Developments/Updates
Table 70. Texcell Competitive Strengths & Weaknesses
Table 71. Intertek Group Basic Information, Manufacturing Base and Competitors
Table 72. Intertek Group Major Business
Table 73. Intertek Group Medical Device Viral Inactivation Testing Product and Services
Table 74. Intertek Group Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Intertek Group Recent Developments/Updates
Table 76. Intertek Group Competitive Strengths & Weaknesses
Table 77. LabCorp Basic Information, Manufacturing Base and Competitors
Table 78. LabCorp Major Business
Table 79. LabCorp Medical Device Viral Inactivation Testing Product and Services
Table 80. LabCorp Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. LabCorp Recent Developments/Updates
Table 82. LabCorp Competitive Strengths & Weaknesses
Table 83. Syensqo Basic Information, Manufacturing Base and Competitors
Table 84. Syensqo Major Business
Table 85. Syensqo Medical Device Viral Inactivation Testing Product and Services
Table 86. Syensqo Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Syensqo Recent Developments/Updates
Table 88. Syensqo Competitive Strengths & Weaknesses
Table 89. SGS Basic Information, Manufacturing Base and Competitors
Table 90. SGS Major Business
Table 91. SGS Medical Device Viral Inactivation Testing Product and Services
Table 92. SGS Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. SGS Recent Developments/Updates
Table 94. SGS Competitive Strengths & Weaknesses
Table 95. Pacific BioLabs Basic Information, Manufacturing Base and Competitors
Table 96. Pacific BioLabs Major Business
Table 97. Pacific BioLabs Medical Device Viral Inactivation Testing Product and Services
Table 98. Pacific BioLabs Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Pacific BioLabs Recent Developments/Updates
Table 100. Pacific BioLabs Competitive Strengths & Weaknesses
Table 101. Creative Biogene Basic Information, Manufacturing Base and Competitors
Table 102. Creative Biogene Major Business
Table 103. Creative Biogene Medical Device Viral Inactivation Testing Product and Services
Table 104. Creative Biogene Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Creative Biogene Recent Developments/Updates
Table 106. Creative Biogene Competitive Strengths & Weaknesses
Table 107. ProPharma Group Basic Information, Manufacturing Base and Competitors
Table 108. ProPharma Group Major Business
Table 109. ProPharma Group Medical Device Viral Inactivation Testing Product and Services
Table 110. ProPharma Group Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. ProPharma Group Recent Developments/Updates
Table 112. ProPharma Group Competitive Strengths & Weaknesses
Table 113. Cormica Lab (Wickham Micro) Basic Information, Manufacturing Base and Competitors
Table 114. Cormica Lab (Wickham Micro) Major Business
Table 115. Cormica Lab (Wickham Micro) Medical Device Viral Inactivation Testing Product and Services
Table 116. Cormica Lab (Wickham Micro) Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Cormica Lab (Wickham Micro) Recent Developments/Updates
Table 118. Cormica Lab (Wickham Micro) Competitive Strengths & Weaknesses
Table 119. CTI Basic Information, Manufacturing Base and Competitors
Table 120. CTI Major Business
Table 121. CTI Medical Device Viral Inactivation Testing Product and Services
Table 122. CTI Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. CTI Recent Developments/Updates
Table 124. CTI Competitive Strengths & Weaknesses
Table 125. WuXi AppTec Basic Information, Manufacturing Base and Competitors
Table 126. WuXi AppTec Major Business
Table 127. WuXi AppTec Medical Device Viral Inactivation Testing Product and Services
Table 128. WuXi AppTec Medical Device Viral Inactivation Testing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. WuXi AppTec Recent Developments/Updates
Table 130. WuXi AppTec Competitive Strengths & Weaknesses
Table 131. Global Key Players of Medical Device Viral Inactivation Testing Upstream (Raw Materials)
Table 132. Global Medical Device Viral Inactivation Testing Typical Customers
LIST OF FIGURES
Figure 1. Medical Device Viral Inactivation Testing Picture
Figure 2. World Medical Device Viral Inactivation Testing Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Medical Device Viral Inactivation Testing Total Revenue (2021-2032) & (USD Million)
Figure 4. World Medical Device Viral Inactivation Testing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Medical Device Viral Inactivation Testing Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Medical Device Viral Inactivation Testing Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Medical Device Viral Inactivation Testing Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Medical Device Viral Inactivation Testing Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Medical Device Viral Inactivation Testing Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Medical Device Viral Inactivation Testing Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Medical Device Viral Inactivation Testing Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Medical Device Viral Inactivation Testing Revenue (2021-2032) & (USD Million)
Figure 13. Medical Device Viral Inactivation Testing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Medical Device Viral Inactivation Testing Consumption Value (2021-2032) & (USD Million)
Figure 16. World Medical Device Viral Inactivation Testing Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Medical Device Viral Inactivation Testing Consumption Value (2021-2032) & (USD Million)
Figure 18. China Medical Device Viral Inactivation Testing Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Medical Device Viral Inactivation Testing Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Medical Device Viral Inactivation Testing Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Medical Device Viral Inactivation Testing Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Medical Device Viral Inactivation Testing Consumption Value (2021-2032) & (USD Million)
Figure 23. India Medical Device Viral Inactivation Testing Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Medical Device Viral Inactivation Testing by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Medical Device Viral Inactivation Testing Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Medical Device Viral Inactivation Testing Markets in 2025
Figure 27. United States VS China: Medical Device Viral Inactivation Testing Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Medical Device Viral Inactivation Testing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Medical Device Viral Inactivation Testing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Medical Device Viral Inactivation Testing Market Size Market Share by Type in 2025
Figure 31. DNA-based
Figure 32. RNA-based
Figure 33. World Medical Device Viral Inactivation Testing Market Size Market Share by Type (2021-2032)
Figure 34. World Medical Device Viral Inactivation Testing Market Size by Biological Characteristics & Structure of Viruse, (USD Million), 2021 & 2025 & 2032
Figure 35. World Medical Device Viral Inactivation Testing Market Size Market Share by Biological Characteristics & Structure of Viruse in 2025
Figure 36. Enveloped Viruses
Figure 37. Non-enveloped Viruses
Figure 38. World Medical Device Viral Inactivation Testing Market Size Market Share by Biological Characteristics & Structure of Viruse (2021-2032)
Figure 39. World Medical Device Viral Inactivation Testing Market Size by Testing Method, (USD Million), 2021 & 2025 & 2032
Figure 40. World Medical Device Viral Inactivation Testing Market Size Market Share by Testing Method in 2025
Figure 41. Biocompatibility Testing
Figure 42. Microbiological & Reusability Validation
Figure 43. Chemical Composition Analysis
Figure 44. World Medical Device Viral Inactivation Testing Market Size Market Share by Testing Method (2021-2032)
Figure 45. World Medical Device Viral Inactivation Testing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 46. World Medical Device Viral Inactivation Testing Market Size Market Share by Application in 2025
Figure 47. Active Implant Medical Devices
Figure 48. Active Medical Equipment
Figure 49. In Vitro Diagnostic Equipment
Figure 50. Ophthalmic Medical Equipment
Figure 51. Vascular Medical Equipment
Figure 52. Other
Figure 53. World Medical Device Viral Inactivation Testing Market Size Market Share by Application (2021-2032)
Figure 54. Medical Device Viral Inactivation Testing Industrial Chain
Figure 55. Methodology
Figure 56. Research Process and Data Source
Figure 1. Medical Device Viral Inactivation Testing Picture
Figure 2. World Medical Device Viral Inactivation Testing Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Medical Device Viral Inactivation Testing Total Revenue (2021-2032) & (USD Million)
Figure 4. World Medical Device Viral Inactivation Testing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Medical Device Viral Inactivation Testing Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Medical Device Viral Inactivation Testing Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Medical Device Viral Inactivation Testing Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Medical Device Viral Inactivation Testing Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Medical Device Viral Inactivation Testing Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Medical Device Viral Inactivation Testing Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Medical Device Viral Inactivation Testing Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Medical Device Viral Inactivation Testing Revenue (2021-2032) & (USD Million)
Figure 13. Medical Device Viral Inactivation Testing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Medical Device Viral Inactivation Testing Consumption Value (2021-2032) & (USD Million)
Figure 16. World Medical Device Viral Inactivation Testing Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Medical Device Viral Inactivation Testing Consumption Value (2021-2032) & (USD Million)
Figure 18. China Medical Device Viral Inactivation Testing Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Medical Device Viral Inactivation Testing Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Medical Device Viral Inactivation Testing Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Medical Device Viral Inactivation Testing Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Medical Device Viral Inactivation Testing Consumption Value (2021-2032) & (USD Million)
Figure 23. India Medical Device Viral Inactivation Testing Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Medical Device Viral Inactivation Testing by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Medical Device Viral Inactivation Testing Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Medical Device Viral Inactivation Testing Markets in 2025
Figure 27. United States VS China: Medical Device Viral Inactivation Testing Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Medical Device Viral Inactivation Testing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Medical Device Viral Inactivation Testing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Medical Device Viral Inactivation Testing Market Size Market Share by Type in 2025
Figure 31. DNA-based
Figure 32. RNA-based
Figure 33. World Medical Device Viral Inactivation Testing Market Size Market Share by Type (2021-2032)
Figure 34. World Medical Device Viral Inactivation Testing Market Size by Biological Characteristics & Structure of Viruse, (USD Million), 2021 & 2025 & 2032
Figure 35. World Medical Device Viral Inactivation Testing Market Size Market Share by Biological Characteristics & Structure of Viruse in 2025
Figure 36. Enveloped Viruses
Figure 37. Non-enveloped Viruses
Figure 38. World Medical Device Viral Inactivation Testing Market Size Market Share by Biological Characteristics & Structure of Viruse (2021-2032)
Figure 39. World Medical Device Viral Inactivation Testing Market Size by Testing Method, (USD Million), 2021 & 2025 & 2032
Figure 40. World Medical Device Viral Inactivation Testing Market Size Market Share by Testing Method in 2025
Figure 41. Biocompatibility Testing
Figure 42. Microbiological & Reusability Validation
Figure 43. Chemical Composition Analysis
Figure 44. World Medical Device Viral Inactivation Testing Market Size Market Share by Testing Method (2021-2032)
Figure 45. World Medical Device Viral Inactivation Testing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 46. World Medical Device Viral Inactivation Testing Market Size Market Share by Application in 2025
Figure 47. Active Implant Medical Devices
Figure 48. Active Medical Equipment
Figure 49. In Vitro Diagnostic Equipment
Figure 50. Ophthalmic Medical Equipment
Figure 51. Vascular Medical Equipment
Figure 52. Other
Figure 53. World Medical Device Viral Inactivation Testing Market Size Market Share by Application (2021-2032)
Figure 54. Medical Device Viral Inactivation Testing Industrial Chain
Figure 55. Methodology
Figure 56. Research Process and Data Source
